Business
Sobi publishes Q1 2025 report: Portfolio continues to deliver
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2025
About this update from Swedish Orphan Biovitrum Ab
[{"type":"text","content":"STOCKHOLM, April 29, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2025","length":143,"tagName":"p"},{"type":"text","content":"First Quarter 2025","length":18,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Total revenue increased 3 per cent, 3 per cent at constant exchange rates, (CER)1, to SEK 6,465 M (6,256)","length":105,"tagName":"p"}]},{"val":[{"type":"text","content":"Haematology revenue increased 13 per cent at CER to SEK 4,632 M (4,075), mainly driven by the launch of Altuvoct of SEK 455 M (0), strong sales of Doptelet of SEK 1,129 M (756) and sales of Aspaveli/Empaveli of SEK 333 M (240), somewhat offset by sales of Vonjo of SEK 306 M (320)","length":280,"tagName":"p"}]},{"val":[{"type":"text","content":"Immunology revenue decreased 21 per cent at CER to SEK 1,526 M (1,908), explained by low Synagis sales of SEK 21 M (520) and Beyfortus royalty of SEK 189 M (318), partially offset by strong sales of Gamifant of SEK 582 M (438) and Kineret of SEK 735 M (633)","length":257,"tagName":"p"}]},{"val":[{"type":"text","content":"Revenue from the strategic portfolio1* grew by 46 per cent at CER to SEK 3,255 M (2,194)","length":88,"tagName":"p"}]},{"val":[{"type":"text","content":"The adjusted EBITA margin1,2 was 36 per cent (37), excluding items affecting comparability (IAC)2. EBITA1 was SEK 2,260 M (2,177), corresponding to a margin of 35 per cent (35). EBIT was SEK 1,358 M (1,313)","length":206,"tagName":"p"}]},{"val":[{"type":"text","content":"Earnings per share (EPS) before dilution was SEK 2.55 (2.35) and EPS after dilution was SEK 2.52 (2.33). Adjusted EPS before dilution was SEK 2.75 (2.70) and adjusted EPS after dilution1 was SEK 2.72 (2.67)","length":206,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash flow from operating activities was SEK 2,295 M (2,256)","length":59,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":1201,"olType":false},{"type":"text","content":"Outlook 2025 - Unchanged","length":24,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue is anticipated to grow by a high single-digit percentage at CER","length":71,"tagName":"p"}]},{"val":[{"type":"text","content":"The adjusted EBITA margin is anticipated to be in the mid-30s percentage of revenue","length":83,"ta...